National Instruments Reports Record Third Quarter Revenue, 19% Growth in Net IncomeLabVIEW 7 Express Drives Double-Digit Software Growth
AUSTIN, Texas -- October 23, 2003 -- National Instruments (Nasdaq: NATI) today reported net income of $8 million, up 19 percent from Q3 2002. Third quarter revenue was a record $105 million, a 9 percent increase from the third quarter of 2002, and the fifth consecutive quarter of year-over-year revenue growth. Fully diluted earnings per share (EPS) for Q3 were 15 cents.
"Our commitment to investing in R&D remains a key driver for our growth," said Dr. James Truchard, NI CEO. "More than 350 man-years of development on LabVIEW 7 Express and next-generation DAQmx driver software has paid off this quarter with strong double-digit software growth. With many new products and record sales for data acquisition, modular instrumentation and distributed I/O products, we delivered 9 percent growth in revenue and 19 percent growth in profitability."
Q3 2003 Highlights
- Record third quarter revenue, fifth consecutive quarter of year-over-year revenue growth
- Revenue up 9 percent, net income up 19 percent year-over-year
- Double-digit growth for software sales and record quarterly sales of data acquisition, modular instrumentation and distributed I/O products
- Major product releases, including PXI 100 MS/s mixed-signal suite, TestStand 3.0, LabWindows/CVI 7.0, Measurement Studio 7.0 and MATRIXx 6.3
- Record cash and short term investments of $172 million
- Cash dividend of 5 cents per common share
"We were pleased to see our growth improve in Q3 and believe this was a result of our strong new product output and an early stage recovery in global manufacturing," said Alex Davern, NI CFO. "We reported record revenue for the first nine months of the year, reinforcing our expectation of record revenue for the year."
Geographically, the growth of revenue in U.S. dollar terms for Q3 2003 as compared to Q3 2002 was as follows: Europe, up 18 percent; Asia, up 18 percent; and Americas, up 1 percent, giving overall growth of 9 percent, up from 7 percent last quarter. In local currency terms, revenue was up 3 percent in Europe, up 33 percent in Asia, up 1 percent in the Americas, giving overall local currency growth of 7 percent, up from 3 percent last quarter.
NI anticipates record revenue for 2003 and expects high single-digit, year-over-year revenue growth in Q4 2003. In addition, the company estimates earnings per share will be in the range of 20 to 23 cents per share for Q4 2003.
Interested parties can listen to a conference call today, Oct. 23, 2003, beginning at 4:00 p.m. CDT, at ni.com/call. Replay information will be available by calling (719) 457-0820, confirmation code #262922, from Oct. 23, 2003 at 7:00 p.m. CDT, through Oct. 30, 2003 at 12:00 a.m. CDT.
This release contains "forward-looking statements," including R&D investment as a driver for growth, recovery in global manufacturing, and the company's expectations regarding record revenue for the year, revenue growth for the fourth quarter, and estimated earnings for the fourth quarter. These statements are subject to a number of risks and uncertainties, including the risk of adverse changes in the global economy, delays in the release of new products, fluctuations in customer demand for NI products, manufacturing inefficiencies, and foreign exchange fluctuations. Actual results may differ materially from the expected results. The company directs you to documents filed with the SEC for other risks associated with the company's future performance.
About National Instruments
National Instruments (www.ni.com) is a technology pioneer and leader in virtual instrumentation -- a revolutionary concept that has changed the way engineers and scientists approach measurement and automation. Leveraging the PC and its related technologies, virtual instrumentation increases productivity and lowers costs for customers worldwide through easy-to-integrate software, such as the NI LabVIEW graphical development environment, and modular hardware, such as PXI modules for data acquisition, instrument control and machine vision. Headquartered in Austin, Texas, NI has more than 3,000 employees and direct operations in 40 countries. In 2002, the company sold products to more than 25,000 different companies in more than 80 countries around the world. For the past four consecutive years, FORTUNE magazine has named NI one of the 100 best companies to work for in America.
Readers may obtain investment information from the company's investor relations department at (512) 683-5090, by sending e-mail to nati@ni.com or on the Web at www.ni.com/nati.
The condensed consolidated balance sheets, statements of income, and cash flows to follow.
National Instruments
Condensed Consolidated Balance Sheets
(in thousands)
|
|
September 30,
2003 (unaudited)
|
December 31,
2002
|
|
ASSETS
|
|
Current assets:
|
|
|
Cash and cash equivalents
|
$ 34,015
|
$ 40,240
|
|
Short-term investments
|
138,210
|
113,638
|
|
Accounts receivable, net
|
68,313
|
62,981
|
|
Inventories
|
38,448
|
39,247
|
|
Other current assets
|
18,199
|
21,860
|
|
Total current assets
|
297,185
|
277,966
|
|
|
|
Property and equipment, net
|
151,126
|
152,133
|
|
Intangibles, net and other assets
|
40,365
|
28,615
|
|
Total assets
|
$488,676
|
$458,714
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
Current liabilities:
|
|
Accounts payable
|
26,108
|
25,578
|
|
Accrued expenses
|
36,021
|
40,935
|
|
Total current liabilities
|
62,129
|
66,513
|
|
|
|
Deferred income taxes
|
5,402
|
5,738
|
|
Total liabilities
|
67,531
|
72,251
|
|
|
|
Stockholders' equity:
|
|
Common stock
|
518
|
511
|
|
Additional paid-in capital
|
86,097
|
72,063
|
|
Retained earnings
|
341,349
|
321,813
|
|
Other
|
(6,819)
|
(7,924)
|
|
Total stockholders' equity
|
421,145
|
386,463
|
|
Total liabilities and stockholders' equity
|
$488,676
|
$458,714
|
National Instruments
Condensed Consolidated Statements of Income
(in thousands, except per share data)
|
|
Three Months
Ended September 30, (unaudited)
|
Nine Months
Ended September 30, (unaudited)
|
|
|
2003
|
2002
|
2003
|
2002
|
|
Net sales
|
$104,644
|
$96,020
|
$303,983
|
$284,264
|
|
Cost of sales
|
27,434
|
25,196
|
80,598
|
77,157
|
|
Gross profit
|
77,210
|
70,824
|
223,385
|
207,107
|
|
|
|
|
|
Sales and marketing
|
40,282
|
36,679
|
116,951
|
105,653
|
|
Research and development
|
18,370
|
16,095
|
50,497
|
47,762
|
|
General and administrative
|
8,438
|
8,224
|
25,244
|
22,559
|
|
Patent litigation
|
362
|
1,220
|
3,796
|
3,513
|
|
Total operating expenses
|
67,452
|
62,218
|
196,488
|
179,487
|
|
|
|
Operating income
|
9,758
|
8,606
|
26,897
|
27,620
|
|
Interest income, net
|
570
|
785
|
1,876
|
2,419
|
|
Foreign exchange, net
|
(209)
|
(612)
|
116
|
(1,288)
|
|
Other income, net
|
486
|
506
|
606
|
1,028
|
|
|
|
Income before income taxes
|
10,605
|
9,285
|
29,495
|
29,779
|
|
Provision for income taxes
|
2,651
|
2,600
|
7,374
|
8,338
|
|
|
|
Net income
|
$7,954
|
$6,685
|
$22,121
|
$21,441
|
|
|
|
Earnings per share:
|
|
Basic
|
$0.15
|
$0.13
|
$0.43
|
$0.42
|
|
Diluted
|
$0.15
|
$0.13
|
$0.41
|
$0.40
|
|
Weighted average shares outstanding:
|
|
Basic
|
51,532
|
51,195
|
51,468
|
51,286
|
|
|
|
Diluted
|
53,932
|
52,906
|
53,719
|
53,603
|
|
Dividends declared per share
|
$0.05
|
--
|
$0.05
|
--
|
National Instruments
Consolidated Statements of Cash Flows
(in thousands)
|
|
Nine Months Ended
September 30, (unaudited)
|
|
|
2003
|
2002
|
|
Cash flow from operating activities:
|
|
Net income
|
$22,121
|
$21,441
|
Adjustments to reconcile net income to cash from operating activities:
|
|
Charges to income not requiring cash outlays:
|
|
Depreciation and amortization
|
18,787
|
14,862
|
|
Benefit from deferred income taxes
|
(514)
|
(3,769)
|
|
Tax benefit from stock option plans
|
2,565
|
1,164
|
|
Changes in operating assets and liabilities:
|
|
Increase in accounts receivable
|
(5,332)
|
(1,894)
|
|
Decrease (increase) in inventory
|
799
|
(7,015)
|
|
Decrease in prepaid expense and other assets
|
4,071
|
3,154
|
|
(Decrease) increase in current liabilities
|
(4,384)
|
5,677
|
|
Net cash provided by operating activities
|
38,113
|
33,620
|
|
|
|
Cash flow from investing activities:
|
|
Payment for acquisitions, net of cash received
|
(5,316)
|
--
|
|
Capital expenditures
|
(12,870)
|
(24,753)
|
|
Capitalization of internally developed software
|
(9,449)
|
(3,025)
|
|
Additions to other intangibles
|
(1,022)
|
(2,214)
|
|
Purchases of short-term investments
|
(105,626)
|
(106,294)
|
|
Sales/maturities of short-term investments
|
81,054
|
130,531
|
|
Net cash used in investing activities
|
(53,229)
|
(5,755)
|
|
|
|
Cash flow from financing activities:
|
|
Proceeds from issuance of common stock
|
11,476
|
6,666
|
|
Repurchase of common stock
|
--
|
(17,420)
|
|
Dividends paid
|
(2,585)
|
--
|
|
Net cash provided by (used in) financing activities
|
8,891
|
(10,754)
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
(6,225)
|
17,111
|
|
Cash and cash equivalents at beginning of period
|
40,240
|
49,089
|
|
Cash and cash equivalents at end of period
|
$ 34,015
|
$ 66,200
|
|
Non-cash financing activities
|
|
|
|
Accrued liability for repurchase of common stock
|
$ --
|
$ 2,203
|
Contact:
Kimberly Allen Investor Relations Manager National Instruments (512) 683-6873 |
Jennifer Howard-Brown Media Relations Manager National Instruments (512) 683-8713 |
###
Related Links:
|